Research - News
Low dietary potassium leads to calcified arteries and aortic stiffness, while increased dietary potassium alleviates those undesirable effects in a mouse model, suggesting dietary potassium may protect against heart disease and death from heart disease in humans.
Chad Thomas Hagwood, Edward E. Partridge, Catherine Danielou, Michelle Cardel and Raymond Thompson were bestowed the awards by the NAS for their personal, academic and professional achievements, service to the community, and philanthropy.
Researchers study the mechanisms that prevent autoimmune diseases like rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis after an infection.
The research supported by the Patient-Centered Outcomes Research Institute will evaluate the effectiveness of different types of exercise programs for people with MS.
The AGHI, a genomics partnership between UAB and HudsonAlpha, is cited for collaboration by Health Connect South.
Virtual reality delivery of CI therapy, a form of physical rehabilitation shown to be highly effective, allows stroke patients to access this complex treatment in their own homes.
UAB and Innovation Depot are among the 42 organizations from 28 states that received more than $17 million to create and expand cluster-focused proof-of-concept and commercialization programs, and early-stage seed capital funds.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.
Physics professor Cheng-Chien Chen will use the fellowship to broaden his research in strongly correlated materials, which could lead to scientific advancement in the energy industry.
UAB will be a fundamental player in the Alabama jurisdiction of the program, which has just five awardees, with primary goals of improving scientific research and building workforce capacity.
A new UAB study will investigate the role of autoantibodies and the benefit of therapeutic plasma exchange on a deadly lung disease.
A UAB study suggests a new bone boosting drug is more effective than commonly used bone loss medications in preventing fractures in women with osteoporosis.
UAB’s Civitan Rett Syndrome Clinic has been named a Center of Excellence by rettsyndrome.org, one of the nation’s leading advocacy groups.
A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.
These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.
This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
UAB is joining the All of Us Research Program, an effort led by the National Institutes of Health to drive precision medicine research.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Due to the current opioid crisis, UAB Hospital has launched an Addiction Scholars Program to train health care professionals across the hospital in caring for patients with addiction issues.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
The inhibitor blocks Streptococcus mutans from sticking on the tooth surface. About 2.3 billion people worldwide have tooth decay in their permanent teeth, primarily caused by this bacteria.
UAB, Alabama’s leader in precision medicine, joins with Huntsville’s HudsonAlpha in CSER2, an NIH project to bring genomic medicine to more children with birth defects or genetic disorders.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.
The Iceberg project is the latest in a line of high-tech freezer technology UAB is working on for NASA.
Improvements in motor function and memory suggest human neurodevelopmental disorders may be amenable to treatment, even after onset of symptoms. According to a researcher, neurodevelopmental disorders with intellectual disability and autism may not need to last a lifetime.
Pediatric neurosurgeons, oncologists and molecular imaging physicians continue to work toward better diagnoses, treatments and cures for childhood cancer.
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Antarctica’s Larsen C ice shelf has broken away from the mainland, resulting in a one-trillion ton iceberg.
The International Space Station carries a bit of Birmingham on board — high-tech freezers designed and built by the UAB School of Engineering to protect vital scientific experiments. From their mini mission control, staff and students describe the unique challenges of keeping NASA science on ice for more than 90 space missions.